Alta Partners Mergers and Acquisitions Summary

Venture Capital Firm Profile

In the last 3 years, Alta Partners has invested in 1 company.

Alta Partners’ most common sectors for investment arelife science (85%) and medical products (11%) . The Firm’s most common investment types include venture (82%) and pipe (9%). In total, Alta Partners has invested in 8 US states and 7 different countries. Its largest (disclosed) acquisition occurred in 2006 when it acquired Portola Pharmaceuticals for $46M.

In the last 3 years, Alta Partners has exited 3 companies. The Firm’s most common exit type is trade sale (54%). Alta Partners’ largest (disclosed) exit occurred in 2019 when it sold Ellie Mae for $3.7B.

Join Mergr to view Alta Partners’ full profile and discover more large private equity firms just like it.

M&A Summary

  • M&A Total Activity143
    • M&A Buy Activity59
    • M&A Sell Activity84
  • Total Sectors Invested 5
  • Total Countries Invested 7
  • M&A Buy/Sell Connections 70

Alta Partners

4 Embarcadero Center Suite 2100,
San Francisco, California 94111
United States
(415) 362-4022
www.altapartners.com
alta@altapartners.com

Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Insurance, Life Science, Medical Products, Technology Hardware

Target Transaction Types: Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, United Kingdom, Western Europe, Eastern Europe, Scandinavia

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (0.2/yr) # 58 - - - 1 - 59
vol $142M $142M
Sell (0.8/yr) # 80 1 1 1 1 - 84
vol $10.6B $3.7B $14.3B
  143

Most Recent M&A

Company Date Value Type
eGenesis 2021-03-02 - Venture
Cambridge, Massachusetts · www.egenesisbio.com
Bioventus LLC 2021-02-04 - IPO
Durham, North Carolina · www.bioventusglobal.com
Sunesis Pharmaceuticals, Inc. 2020-11-30 - Merger
South San Francisco, California · www.sunesis.com
Ellie Mae, Inc. 2019-02-12 3.7B USD Secondary Buyout
Pleasanton, California · www.elliemae.com
ViroBay, Inc. 2018-11-01 - Bankruptcy
Menlo Park, California
DiscoveRx Corp. 2017-07-31 - Add-on Acquisition
Fremont, California · www.discoverx.com
Threshold Pharmaceuticals, Inc. 2017-03-17 - Merger
South San Francisco, California · www.thresholdpharm.com
ZS Pharma, Inc. 2015-11-05 2.7B USD Add-on Acquisition
Coppell, Texas · www.zspharma.com
Kiadis Pharma BV 2015-06-01 - IPO
Amsterdam, Netherlands · www.kiadis.com
aTyr Pharma, Inc. 2015-04-06 - IPO
San Diego, California · www.atyrpharma.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 2 (100%) - 50 (85%) 131M (92%)
Medical Products - - 6 (10%) 11M (8%)
Semiconductors - - 1 (2%) -
Software - - 1 (2%) -
Technology Hardware - - 1 (2%) -
Total 2 - 59 $142M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 2 (100%) - 51 (86%) 142M (100%)
  California - - 32 (54%) 103M (72%)
  Massachusetts 2 (100%) - 8 (14%) 23M (16%)
  North Carolina - - 3 (5%) 17M (12%)
  Texas - - 2 (3%) -
  Pennsylvania - - 2 (3%) -
  Maryland - - 2 (3%) -
  Washington - - 1 (2%) -
  Florida - - 1 (2%) -
France - - 2 (3%) -
Sweden - - 2 (3%) -
United Kingdom - - 1 (2%) -
Belgium - - 1 (2%) -
Denmark - - 1 (2%) -
Netherlands - - 1 (2%) -
Domestic 2 (100%) - 51 (86%) 142M (100%)
Cross-border - - 8 (14%) -
Total 2 - 59 $142M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 2 (100%) - 48 (81%) 142M (100%)
PIPE - - 5 (8%) -
Buyout (LBO, MBO, MBI) - - 4 (7%) -
Growth Capital - - 2 (3%) -
Total 2 - 59 $142M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 39 (46%) 8.5B (61%)
IPO 32 (38%) -
Trade Sale 6 (7%) 1.8B (13%)
Bankruptcy 4 (5%) -
Merger 2 (2%) -
Secondary Sale 1 (1%) 3.7B (26%)
Total 84 $14.0B

Deal Values

buy # Total
< $100M 6 $142M
TOTAL $142M
Largest Portola Pharmaceuticals, Inc.
$46M (2006-11-08)
sell # Total
> $1B 3 $7.4B
$100M to $1B 18 $6.8B
< $100M 2 $97M
TOTAL $14.3B
Largest Ellie Mae, Inc.
$3.7B (2019-02-12)

M&A Connections

Deals
Exited to
Investor(s)
1%
1 (1%)
Strategic(s)
56%
47 (56%)

Investor Summary

Investor Type

Venture Capital Firm

Size

Large

PE Assets

2.0B USD

Established

1996

Specialist/Generalist

Specialist

Leadership

Dan Janney

Co-Founder & Managing Director

Bob More

Managing Director

Pete Hudson

Managing Director

Larry Randall

CFO

 Subscribe to unlock this and 185,641
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.4K Private Equity Firms
  • 176K M&A Transactions
  • 181K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 66K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal